Janux Therapeutics Inc (JANX)
29.12 x 1 35.09 x 2
Post-market by (Cboe BZX)
29.94 -0.49 (-1.61%) 03/21/25 [NASDAQ]
29.12 x 1 35.09 x 2
Post-market 29.94 unch (unch) 16:55 ET
for Fri, Mar 21st, 2025
Results
download Want to compare other data? Select Fields| Symbol | JANX | MESO | CERT | ||
| Company | Janux Therapeutics Inc | Mesoblast Ltd ADR | Certara Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 29.93 | 13.75 | 10.40 | ||
| High | 30.56 | 14.06 | 10.76 | ||
| Low | 29.76 | 13.60 | 10.21 | ||
| Last | 29.94 | 13.94 | 10.73 | ||
| Change | -0.49 | +0.26 | +0.13 | ||
| % Change | -1.61% | +1.94% | +1.23% | ||
| Volume | 1,514,600 | 270,500 | 1,763,200 | ||
| 20-Day Average Volume | 924,365 | 388,165 | 1,466,250 | ||
| Previous Close | 30.43 | 13.68 | 10.60 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 31.28 | 14.35 | 11.45 | ||
| 20-Day Raw Stochastic | 13.92% | 31.53% | 16.99% | ||
| 20-Day Relative Strength | 36.09% | 42.65% | 37.47% | ||
| Weighted Alpha | -59.13 | +136.61 | -36.75 | ||
| Today's Opinion | 88% Sell | 24% Buy | 56% Sell | ||
| Previous Opinion | 88% Sell | 24% Buy | 56% Sell | ||
| Last Month's Opinion | 56% Sell | 72% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.41% since 03/14/25 | +2.88% since 03/14/25 | -1.74% since 03/14/25 | ||
| Low | 29.76 on 03/21/25 | 12.94 on 03/18/25 | 10.21 on 03/21/25 | ||
| High | 31.95 on 03/20/25 | 14.06 on 03/21/25 | 11.39 on 03/17/25 | ||
| 1-Month | |||||
| %Chg | -16.86% since 02/21/25 | -14.84% since 02/21/25 | -18.53% since 02/21/25 | ||
| Low | 28.92 on 03/11/25 | 12.40 on 03/10/25 | 10.21 on 03/21/25 | ||
| High | 36.25 on 02/24/25 | 17.28 on 02/28/25 | 13.27 on 02/27/25 | ||
| 3-Month | |||||
| %Chg | -47.32% since 12/20/24 | -4.72% since 12/20/24 | +0.19% since 12/20/24 | ||
| Low | 28.92 on 03/11/25 | 12.40 on 03/10/25 | 10.21 on 03/21/25 | ||
| High | 61.59 on 01/07/25 | 22.00 on 12/30/24 | 15.69 on 02/14/25 | ||
| 6-Month | |||||
| %Chg | -40.36% since 09/20/24 | +103.50% since 09/20/24 | -1.56% since 09/20/24 | ||
| Low | 28.92 on 03/11/25 | 6.62 on 09/23/24 | 9.41 on 11/21/24 | ||
| High | 71.71 on 12/05/24 | 22.00 on 12/30/24 | 15.69 on 02/14/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,769,604 | 1,771,119 | 1,727,723 | ||
| Shares Outstanding, K | 59,105 | 127,053 | 161,018 | ||
| Annual Sales | 10,590,000 | 5,900,000 | 385,150,000 | ||
| Annual Net Income | -68,990,000 | -87,960,000 | -12,050,000 | ||
| Last Quarter Sales | 440,000 | 1,930,000 | 100,360,000 | ||
| Last Quarter Net Income | -28,060,000 | -21,920,000 | 6,580,000 | ||
| 60-Month Beta | 3.23 | 3.40 | 1.60 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.36 on 02/27/25 | N/A on 09/06/19 | 0.15 on 02/26/25 | ||
| Latest Earnings Date | 05/06/25 | 09/04/24 | 05/06/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 36.55 | ||